(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(0.29%) $78.34
(0.19%) $2.15
(0.40%) $2 317.90
(1.69%) $27.14
(-0.51%) $960.40
(0.02%) $0.929
(-0.09%) $10.86
(0.01%) $0.797
(0.00%) $91.45
5.95% $ 6.95
@ $6.89
Wydano: 14 vas. 2024 @ 21:38
Zwrot: 0.87%
Poprzedni sygnał: vas. 14 - 20:38
Poprzedni sygnał:
Zwrot: -2.96 %
Live Chart Being Loaded With Signals
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer...
Stats | |
---|---|
Dzisiejszy wolumen | 631 256 |
Średni wolumen | 1.14M |
Kapitalizacja rynkowa | 426.65M |
EPS | $0 ( 2024-02-08 ) |
Następna data zysków | ( $-0.860 ) 2024-05-16 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.20 |
ATR14 | $0.00900 (0.13%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Peeples-dyer Veleka | Buy | 32 000 | Stock Option (right to buy) |
2024-04-01 | Patel Sushil | Buy | 250 000 | Employee Stock Option (right to buy) |
2024-04-01 | Patel Sushil | Buy | 83 335 | Common Stock |
2024-04-01 | Pucci Paolo | Buy | 32 000 | Stock Option (right to buy) |
2024-04-01 | Xynos Konstantinos | Buy | 26 665 | Common Stock |
INSIDER POWER |
---|
74.56 |
Last 98 transactions |
Buy: 2 588 053 | Sell: 457 936 |
Wolumen Korelacja
Replimune Group Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
BNIXU | 0.927 |
CASS | 0.908 |
ATIF | 0.895 |
COLL | 0.894 |
COFS | 0.893 |
CNXC | 0.893 |
NIU | 0.888 |
FCBP | 0.887 |
DRTT | 0.884 |
BTAI | 0.882 |
10 Najbardziej negatywne korelacje | |
---|---|
MTEK | -0.873 |
NGMS | -0.849 |
CRSA | -0.842 |
PPBT | -0.839 |
RMRM | -0.833 |
PLMR | -0.83 |
SLDP | -0.828 |
OSMT | -0.828 |
MVBF | -0.821 |
TCRX | -0.821 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Replimune Group Inc Korelacja - Waluta/Towar
Replimune Group Inc Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-2.45M (0.00 %) |
EPS: | $-2.99 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-2.45M (0.00 %) |
EPS: | $-2.99 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-4.58M (0.00 %) |
EPS: | $-2.26 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.750 |
Financial Reports:
No articles found.
Replimune Group Inc
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes simplex virus 1, which is in Phase I/II clinical trials for a range of solid tumors; and that is in Phase II clinical trials for patients with cutaneous squamous cell carcinoma. It is also developing RP2, which is in Phase I clinical trials for an anti-CTLA-4 antibody-like protein in order to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trials to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej